Javier García-Abellán

15PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersPhotography, video and lens-based practicePharmacogenomicsGenome structure and regulationRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 03, 2026
Human papillomavirus 68 subtypes among people with human immunodeficiency virus and implications for anal screening.

|Nov 14, 2025
Virological Success With Long-Acting Cabotegravir and Rilpivirine Despite Historical Rilpivirine Resistance: A Real-World Case Series.

Félix Gutiérrez, Marta Fernández-González, Christian Ledesma

|Jun 05, 2025
Influence of patient characteristics and oral lead-in on long-acting cabotegravir and rilpivirine pharmacokinetics and outcomes in people with HIV: a real-world study.

Marta Fernández-González, Guillermo Telenti, Christian Ledesma

|Jun 05, 2025
Gut microbiota and weight gain in people with HIV on integrase inhibitors: a five-year longitudinal study.

Javier García-Abellán, José A García, Ronald Galdámez

|Mar 05, 2025
Impact of Switching to Long-Acting Injectable Cabotegravir Plus Rilpivirine on Rectal HIV-1 RNA Shedding and Implications for Transmission Risk.

Mar Masiá, Marta Fernández-González, Christian Ledesma

|Oct 25, 2024
No accelerated progression of subclinical atherosclerosis with integrase strand transfer inhibitors compared to non-nucleoside reverse transcriptase inhibitors.

Javier García-Abellán, José A García, Sergio Padilla

Pageof 3

Frequent Collaborators

13 joint publications

Mar Masiá

12 joint publications

Marta Fernández-González

12 joint publications

Félix Gutiérrez

12 joint publications

Sergio Padilla